Inventor
KISHIMOTO TAKASHI KEI
US25 patents
⚠️ This page may combine multiple inventors who share the name “KISHIMOTO TAKASHI KEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SELECTA BIOSCIENCES INC
9 patentsUS10441651B2Oct 15, 2019
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
SELECTA BIOSCIENCES INC16 citations94
US10434088B2Oct 8, 2019
Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
SELECTA BIOSCIENCES INC15 citations94
US10420835B2Sep 24, 2019
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
SELECTA BIOSCIENCES INC17 citations94
US10357483B2Jul 23, 2019
Methods comprising dosing combinations for reducing undesired humoral immune responses
SELECTA BIOSCIENCES INC14 citations94
US10335395B2Jul 2, 2019
Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance
SELECTA BIOSCIENCES INC14 citations94
US10071114B2Sep 11, 2018
Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
SELECTA BIOSCIENCES INC20 citations94
US10046064B2Aug 14, 2018
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
SELECTA BIOSCIENCES INC21 citations94
US11633422B2Apr 25, 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses
SELECTA BIOSCIENCES INC6 citations85
US11779641B2Oct 10, 2023
Tolerogenic synthetic nanocarriers for allergy therapy
SELECTA BIOSCIENCES INC3 citations84
FRASER CHRISTOPHER
3 patentsUS9987354B2Jun 5, 2018
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
FRASER CHRISTOPHER29 citations97
US9295718B2Mar 29, 2016
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
FRASER CHRISTOPHER33 citations97
US9289477B2Mar 22, 2016
Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
FRASER CHRISTOPHER30 citations97
SUNDARAM MALLIKARJUN
3 patentsUS8592393B2Nov 26, 2013
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
SUNDARAM MALLIKARJUN6 citations81
US8569262B2Oct 29, 2013
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
SUNDARAM MALLIKARJUN6 citations81
US9351992B2May 31, 2016
Non-anticoagulant polysaccharide compositions
SUNDARAM MALLIKARJUN0 citations39
MOMENTA PHARMACEUTICALS INC
3 patentsUS9358252B2Jun 7, 2016
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
MOMENTA PHARMACEUTICALS INC0 citations51
US9212233B2Dec 15, 2015
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
MOMENTA PHARMACEUTICALS INC0 citations51
US9163047B2Oct 20, 2015
Saccharide structures and methods of making and using such structures
MOMENTA PHARMACEUTICALS INC0 citations50